Kim HN, Newcomb CW, Carbonari DM, Roy JA Torgersen J, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Sun J, Hull M, Gill MJ, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Lo Re V 3rd. Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America. Hepatology. 2021 Mar 29;. doi: 10.1002/hep.31839.
Kennedy K, Graham SM, Arora N, Shuhart MC, Kim HN. Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis. PLoS One. 2018 Sep 25; 13(9):e0204031.
• PubMed PMID: 30252863
Kim HN, Nance R, Van Rompaey S, Delaney JC, Crane HM, et al. Poorly controlled HIV infection: an independent risk factor for liver fibrosis. J Acquir Immune Defic Syndr. 2016 Aug 1; 72(4):437-43.
• PubMed Abstract
Kim HN, Rodriguez CV, Van Rompaey S, et. al. Factors associated with delayed hepatitis B viral suppression on Tenofovir among HBV-HIV coinfected patients in the CNICS cohort. J Acquir Immune Defic Syndr. 2014; 66:96-101.
• PubMed Abstract
Kim HN, Scott J, Cent A, Cook L, Ashley-Morrow R, Richardson B, et al. HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya. J Viral Hep. 2011; 18(10):e447-52.
•PubMed Abstract